Marie Aouad-Maroun

Marie Aouad-Maroun

Auto-generated profile, based on publicly available information

Marie Aouad-Maroun

Affiliation Department of Anesthesiology, American University of Beirut Medical Center, Beirut, Lebanon

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in Anesthesiology
Verified
Journal Article
Closed access
PDF file
MAMarie T. Aouad
Marie T. Aouad
VYVanda G. Yazbeck-Karam
Vanda G. Yazbeck-Karam
VNViviane G. Nasr
Viviane G. Nasr
MEMohamad F. El-Khatib
Mohamad F. El-Khatib
GKGhassan E. Kanazi
Ghassan E. Kanazi
JBJamal H. Bleik
Jamal H. Bleik
THE occurrence of emergence agitation in children after sevoflurane anesthesia is common, with an incidence ranging between 10% and 80%.1,2 Different drugs such as nonopioid analgesics,3,4 opioids,5 benzodiazepines,6 intravenous anesthetics,7 and α2agonists2,8–10 have been used with variable success to allow a smooth emergence from sevoflurane anesthesia. Also, a wide variety of measurement tools have been used to assess this postanesthetic phenomenon, which makes comparisons of the results between studies difficult.

7 March 2005 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
MAM. T. Aouad
M. T. Aouad
GKG. E. Kanazi
G. E. Kanazi
SSS. M. Siddik‐Sayyid
S. M. Siddik‐Sayyid
FGF. J. Gerges
F. J. Gerges
LRL. B. Rizk
L. B. Rizk
ABA. S. Baraka
A. S. Baraka

1 December 2005 in Current Opinion in Anaesthesiology
Verified
Journal Article
Closed access
MAMarie T Aouad
Marie T Aouad
VNViviane G Nasr
Viviane G Nasr
In this review, the most recent and relevant developments in the field of emergence agitation in children, as related to its assessment, etiology, and management, are discussed. Studies have shown that a more specific assessment tool is needed to decrease measurement errors. Such scales have been developed recently and incorporate cognitive-related assessment items in addition to agitation behaviors. Young, emotional, impulsive and less social children with anxious parents undergoing head and neck surgery are identified to be at risk for the development of emergence agitation. Factors that may influence the occurrence of this postanesthetic behavior include the level of preoperative anxiety and premedication, anesthesia drugs, as well as awakening in a hostile environment and feeling pain. Management include ruling out all possible causes, such as physiologic compromise, physical discomfort and pain. Treatment of emergence agitation is usually not required since the condition is self-limiting. If unremitting, however, treatment with opioids, benzodiazepines or small doses of hypnotics may be required. It is recommended that children at high risk are identified in order to decrease their level of preoperative anxiety, to supplement low-solubility inhalational agents with adjuvant drugs, to prevent postoperative pain and to allow parents to be with their children during recovery from anesthesia.

1 February 2007 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
MAM. T. Aouad
M. T. Aouad
SSS. M. Siddik-Sayyid
S. M. Siddik-Sayyid
STS. K. Taha
S. K. Taha
MAM. S. Azar
M. S. Azar
VNV. G. Nasr
V. G. Nasr
ABA. S. Baraka
A. S. Baraka
Ondansetron is widely used for the prophylaxis of postoperative nausea and vomiting, while haloperidol is an antiemetic that lacks recent data on efficacy and adverse effects. In this prospective, randomized, double-blinded study involving 93 females undergoing gynaecological procedures under general anaesthesia, we compared the efficacy and adverse effects of prophylactic haloperidol 1 mg intravenous and ondansetron 4 mg intravenous vs. placebo. During the overall observation period (0-24 h), in the haloperidol, ondansetron and placebo groups respectively, the incidence of nausea and/or vomiting was 40.7% (11/27), 48.2% (13/27) and 55.5% (15/27), and the need of rescue antiemetics was 22.2% (6/27), 44.4% (12/27) and 40.7% (11/27), with P values >0.05 among the three groups. During the early observation period (0-2 h), in the haloperidol, ondansetron and placebo groups respectively, the incidence of nausea and/or vomiting was 13.7% (4/29), 26.6% (8/30) and 43% (13/30), and the need for rescue antiemetics was 6.8% (2/29), 26.6% (8/30) and 36.6% (11/30). Between haloperidol and placebo groups, the P value was 0.04 for nausea and/or vomiting, and was 0.01 for rescue antiemetics, in addition to lower nausea scores (P = 0.03). During the late observation period (2-24 h), no significant difference was shown among the three groups. The prophylactic administration of 1 mg intravenous haloperidol or 4 mg ondansetron, in female patients undergoing gynaecological surgery, did not improve the overall incidence of nausea and/or vomiting vs. placebo. However, haloperidol 1 mg proved to be an effective antiemetic in the early observation period without significant adverse effects.

9 March 2012 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Closed access
PDF file
GKGhassan E. Kanazi
Ghassan E. Kanazi
MEMohammad F. El-Khatib
Mohammad F. El-Khatib
VKVanda G. Yazbeck- Karam
Vanda G. Yazbeck- Karam
JHJanane E. Hanna
Janane E. Hanna
BMBadiaa Masri
Badiaa Masri
MAMarie T. Aouad
Marie T. Aouad

14 September 2016 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MAMarie Aouad-Maroun
Marie Aouad-Maroun
CRChristian K Raphael
Christian K Raphael
SSSamia K Sayyid
Samia K Sayyid
FFFadi Farah
Fadi Farah
EAElie A Akl
Elie A Akl